Taking steps to improve recruitment of typically underrepresented populations in cardiovascular clinical trials can pay off, as shown by the design of the Lp(a)FRONTIERS EXPANSION trial.
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
(Founding Partner)
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.
